Clinical characteristics and outcomes of COVID-19 infection in Chinese patients with hematologic malignancies in the Omicron era-Reference-Cited by-同舟云学术

Clinical characteristics and outcomes of COVID-19 infection in Chinese patients with hematologic malignancies in the Omicron era

Published:2023-12 Issue:1 Volume:28 Page:
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Li Xian¹,Zhao Aiqi¹,Jiang Huifang²,Lu Ying³,Le Jing⁴,Xie Yaping⁵,Hu Meiwei⁶,Zeng Hui⁷,Zhao Jianzhi⁸,Zhou Mei⁹,Zhou Hui¹⁰,Chen Lili¹¹,Zhu Weiguo¹²,Ouyang Guifang¹³,Qiu Huiqing¹⁴,Jiang Songfu¹⁵,Guo Qunyi¹⁶,Qian Wenbin¹,Liang Yun¹

Affiliation:

1. Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, People’s Republic of China

2. Department of Hematology, TongDe Hospital of Zhejiang Province, Hangzhou, People’s Republic of China

3. Department of Hematology, The Affiliated People’s Hospital of Ningbo University, Ningbo, People’s Republic of China

4. Department of Hematology, Ningbo Medical Center Li Huili Hospital, Ningbo, People’s Republic of China

5. Department of Hematology, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China

6. Department of Hematology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, People’s Republic of China

7. Department of Hematology, The First Affiliated Hospital of Jiaxing University, Jiaxing, People’s Republic of China

8. Department of Hematology, Shaoxing Center Hospital, Shaoxing, People’s Republic of China

9. Department of Hematology, Zhuji People’s Hospital, Zhuji, People’s Republic of China

10. Department of Hematology, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, People’s Republic of China

11. Department of Medical Oncology, Taizhou First People’s Hospital, Taizhou, People’s Republic of China

12. Department of Hematology, Shaoxing Second Hospital, Shaoxing, People’s Republic of China

13. Department of Hematology, Ningbo First Hospital, Ningbo, People’s Republic of China

14. Department of Hematology and Medical Oncology, The Second People’s Hospital of Quzhou, Quzhou, People’s Republic of China

15. Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People’s Republic of China

16. Department of Hematology and Medical Oncology, Enze Medical Center, Taizhou, People’s Republic of China

Funder

the Major Project of Enze Medical Center

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/16078454.2023.2288477

Reference19 articles.

1. COVID-19 in persons with haematological cancers

2. Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain

3. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients

4. China CDC. COVID-19 clinical and surveillance data — December 9 2022 to January 23 2023 China. China CDC Weekly 2023. https://weekly.chinacdc.cn/news/covid-surveillance/bfa0d054-d5bf-42bb-b8b4-f7ce34539b74_en.htm.